Petek, Bojana
Häbel, Henrike
Xu, Hong
Villa-Lopez, Marta
Kalar, Irena
Hoang, Minh Tuan
Maioli, Silvia
Pereira, Joana B.
Mostafaei, Shayan
Winblad, Bengt
Gregoric Kramberger, Milica
Eriksdotter, Maria
Garcia-Ptacek, Sara
Funding for this research was provided by:
Stiftelsen Dementia
Margaretha af Ugglas Foundation
Health, Medicine and Technique grants from the Stockholm Region and Kungliga Tekniska Högskolan
Johanniterorden i Sverige/Swedish Order of St John
Medicinska Forskningsrådet (2020-02014, 2022-01425)
Karolinska Institutet Research Foundation
Karolinska Institutet Foundation for Diseases of Aging
The Erling Persson foundation
New Innovative Research grants
Innovative ways to fight Alzheimer´s disease - Leif Lundblad Family and others
Karolinska Institute
Article History
Received: 6 August 2023
Accepted: 28 November 2023
First Online: 20 December 2023
Declarations
:
: This study complies with the Declaration of Helsinki and was approved by the regional human ethics committee in Stockholm (numbers: 2015/743-31/4 and 2017/942-32). All patients and their relatives were informed of inclusion in SveDem at the time of diagnosis and had the right to decline the participation or withdraw the data from the registry at any point. The data were de-identified before analysis.
: Not applicable.
: SGP holds stock in AstraZeneca, Bioarctic, Calliditas, Camurus, Dynavax, Moderna, Novo Nordisk, Pfizer, Sanofi, and Vicore. The other authors report no conflicts of interest.